Patent · US Active

Peptides isolated from spider venom, and uses thereof

US8399026B2 · kind B2 · utility

4Cited by

5References

12Claims

0Family size

Assignee

Alomone Preclinical Ltd. · IL

Inventors

Alon MEIR · Jerusalem, IL
Ronit Simcha Cherki · Jerusalem, IL
Ela Kolb · Jerusalem, IL
Yael Langut · Haifa, IL
Nissim Bajayo · Jerusalem, IL

Key dates

Filing date	Sep 14, 2010
Grant date	Mar 19, 2013
Priority date	—
Expiry date	Oct 22, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The presently described subject matter relates to isolated spider venom peptides, which are used as potent and selective ion channel blockers, and to a composition and methods for treatment of pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.